(18)F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study

PURPOSE: To determine whether interim 3′-deoxy-3′-[(18)F]fluorothymidine (iFLT) PET/CT is a superior predictor of progression-free survival (PFS) compared with interim (18)F-fluorodeoxyglucose (iFDG) PET/CT in patients with diffuse large B cell lymphoma (DLBCL) treated with rituximab, cyclophosphami...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur J Nucl Med Mol Imaging
Asıl Yazarlar: Minamimoto, Ryogo, Fayad, Luis, Vose, Julie, Meza, Jane, Advani, Ranjana, Hankins, Jordan, Mottaghy, Felix, Macapinlac, Homer, Heinzel, Alexander, Juweid, Malik E., Quon, Andrew
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2021
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8263539/
https://ncbi.nlm.nih.gov/pubmed/33909086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-021-05353-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller